Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: July 20, 2018

DrugPatentWatch Database Preview

Wes Pharma Inc Company Profile

« Back to Dashboard

What is the competitive landscape for WES PHARMA INC, and what generic and branded alternatives to WES PHARMA INC drugs are available?

WES PHARMA INC has four approved drugs.

Summary for Wes Pharma Inc

US Patents:	0
Tradenames:	3
Ingredients:	3
NDAs:	4

Drugs and US Patents for Wes Pharma Inc

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wes Pharma Inc	HYDROCODONE BITARTRATE AND ACETAMINOPHEN	acetaminophen; hydrocodone bitartrate	TABLET;ORAL	210211-002	Oct 30, 2017	AA	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Wes Pharma Inc	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	207510-001	Mar 21, 2018	AA	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Wes Pharma Inc	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	207510-002	Mar 21, 2018	AA	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Wes Pharma Inc	OXYCODONE HYDROCHLORIDE	oxycodone hydrochloride	SOLUTION;ORAL	207511-001	Nov 23, 2016	AA	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Wes Pharma Inc

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji

Fish and Richardson

Deloitte

Cipla

Queensland Health

Boehringer Ingelheim

Medtronic

McKesson

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.